| Oriflame Investment Holding, FRN 4may2026, EUR (XS2337349265) |
| Nestle S.A., 1.625% 15jul2026, CHF (A) (CH1194355108) |
| Coca-Cola HBC AG, 3.125% 20nov2032, EUR (8) (XS2934874566) |
| ABB, 4.375% 8may2042, USD (US00037BAC63) |
| UBS, 3.625% 9sep2024, USD (US22546QAP28) |
| Credit Suisse Group AG, 7.125% perp., USD (CH0352765157) |
| Avolta, 2.5% 15oct2024, EUR (XS1699848914) |
| Credit Suisse Group AG, 7.5% perp., USD (USH3698DBW32) |
| UBS Group, 0.25% 29jan2026, EUR (22) (CH0520042489) |
| Novartis, 0% 23sep2028, EUR (XS2235996217) |
| Dufry ONE BV, 0.75% 30mar2026, CHF (Conv.) (CH1105195684) |
| Inselspital-Stiftung, 0.125% 28sep2029, CHF (CH1132966354) |
| Zurich Insurance Company, 3.5% 2may2052, USD (59) (XS2416978190) |
| UBS Group, 0.25% 29jan2026, EUR (22) (CH0520042489) |
| Novartis, 0% 23sep2028, EUR (XS2235996217) |
| Dufry ONE BV, 0.75% 30mar2026, CHF (Conv.) (CH1105195684) |
| Inselspital-Stiftung, 0.125% 28sep2029, CHF (CH1132966354) |
| Zurich Insurance Company, 3.5% 2may2052, USD (59) (XS2416978190) |
| Glencore International AG, 4.907% 1apr2028, USD (USU37818BU18) |
| Glencore International AG, 6.141% 1apr2055, USD (USU37818BX56) |
| Glencore International AG, 4.125% 30may2023, USD (XS0938722666) |
| Credit Suisse, 6.5% 8aug2023, USD (XS0957135212) |
| Credit Suisse (Guernsey Branch), 2.25% 15jul2039, EUR (XS1088825143) |
| Allied World Assurance Co Holdings, 4.35% 29oct2025, USD (US01959EAC21) |
| Credit Suisse Group AG, 3.875% perp., CHF (CH0360172719) |
| Julius Baer Bank, 4.75% perp., USD (XS1679216801) |
| Novartis, 1.375% 14aug2030, EUR (XS1769041192) |
| UBS Group, 7% perp., USD (USH4209UAT37) |
| ABB, 1% 7may2029, CHF (CH0457206818) |
| Glencore International AG, 3.125% 26mar2026, GBP (28) (XS1968703345) |
| Orascom Development Holding, 3.25% 11oct2024, CHF (CH0500709925) |
| Banque Cantonale de Geneve, 1.875% perp., CHF (CH0503924372) |
| Wizz Air Holdings, 1% 19jan2026, EUR (2) (XS2433361719) |
| Wizz Air Holdings, 1% 19jan2026, EUR (2) (XS2433361719) |
| Amrize AG, 4.95% 7apr2030, USD (USU4335PAC33) |
| Novartis, 0.625% 13nov2029, CHF (CH0270190991) |
| Holcim, 3% perp., EUR (XS1713466495) |
| UBS Group, 3.126% 13aug2030, USD (19) (USH42097AZ05) |
| Credit Suisse Group AG, 5.1% perp., USD (USH3698DCV40) |
| Novartis, 2.2% 14aug2030, USD (US66989HAR93) |
| Swiss Re AG, 3.125% 3jul2035, SGD (XS2191441489) |
| Ferring Holding, 1.05% 9jul2025, CHF (CH0553331809) |
| UBS Group, 1.364% 30jan2027, USD (USH42097BT36) |
| IWG, 0.5% 9dec2027, GBP (Conv.) (XS2270378149) |
| Wizz Air Holdings, 1.35% 19jan2024, EUR (1) (XS2288097483) |
| UBS, 0.899% 18dec2025, JPY (11) (JP575608CFC0) |
| UBS (London Branch), 3.05% 15oct2031, CNY (SPLB2021-4142) (XS2394881291) |
| VistaJet Malta Finance, 7.875% 1may2027, USD (USX9814HAD53) |
| UBS Group, FRN 12may2026, USD (USH42097DA27) |
| Credit Suisse Group AG, 5.1% perp., USD (USH3698DCV40) |
| Novartis, 2.2% 14aug2030, USD (US66989HAR93) |
| Swiss Re AG, 3.125% 3jul2035, SGD (XS2191441489) |
| Ferring Holding, 1.05% 9jul2025, CHF (CH0553331809) |
| UBS Group, 1.364% 30jan2027, USD (USH42097BT36) |
| IWG, 0.5% 9dec2027, GBP (Conv.) (XS2270378149) |
| Wizz Air Holdings, 1.35% 19jan2024, EUR (1) (XS2288097483) |
| UBS, 0.899% 18dec2025, JPY (11) (JP575608CFC0) |
| UBS (London Branch), 3.05% 15oct2031, CNY (SPLB2021-4142) (XS2394881291) |
| VistaJet Malta Finance, 7.875% 1may2027, USD (USX9814HAD53) |
| UBS Group, FRN 12may2026, USD (USH42097DA27) |
| Syngenta Finance N.V., 1.625% 1nov2024, CHF (CH0240672227) |
| Zurich Insurance Company, 4.75% perp., USD (XS1449950663) |
| UBS Group, 5% perp., USD (CH0400441280) |
| Swiss Life Holding AG, 2.625% 25sep2048, CHF (CH0406990801) |
| Transocean Ltd, 7.25% 1nov2025, USD (USG90073AD26) |
| Basilea Pharmaceutica, 3.25% 28jul2027, CHF (Conv.) (CH0554992062) |
| Julius Baer Bank, 4.875% perp., USD (XS2238020445) |
| Glencore International AG, 0.75% 1mar2029, EUR (34) (XS2307764238) |
| Credit Suisse (London Branch), 0% 15apr2024, RUB (1090D, Structured) (XS2321593910) |
| Meyer Burger Technology, 3.5% 8jul2027, EUR (Conv.) (CH1118223390) |
| Adecco, 1% 21mar2082, EUR (XS2388141892) |
| Glencore International AG, 2.625% 23sep2031, USD (USU37818BC10) |
| Aptiv, 3.1% 1dec2051, USD (US03835VAJ52) |
| Basilea Pharmaceutica, 3.25% 28jul2027, CHF (Conv.) (CH0554992062) |
| Julius Baer Bank, 4.875% perp., USD (XS2238020445) |
| Glencore International AG, 0.75% 1mar2029, EUR (34) (XS2307764238) |
| Credit Suisse (London Branch), 0% 15apr2024, RUB (1090D, Structured) (XS2321593910) |
| Meyer Burger Technology, 3.5% 8jul2027, EUR (Conv.) (CH1118223390) |
| Adecco, 1% 21mar2082, EUR (XS2388141892) |
| Glencore International AG, 2.625% 23sep2031, USD (USU37818BC10) |
| Aptiv, 3.1% 1dec2051, USD (US03835VAJ52) |
| Amrize AG, 5.4% 7apr2035, USD (USU4335PAD16) |
| Nestle S.A., 2.25% 30nov2023, GBP (XS0860561942) |
| Credit Suisse Group AG, 6.25% perp., USD (XS1076957700) |
| UBS Group, 5.75% perp., EUR (CH0271428309) |
| Lindt & Spruengli, 1% 8oct2024, CHF (CH0255475292) |
| GZO AG, 1.875% 12jun2024, CHF (CH0240109618) |
| Aptiv, 1.5% 10mar2025, EUR (XS1197775692) |
| UBS Group, 0% 29jan2027, ITL (10957D) (XS0071948540) |
| Swiss Re, 6.05% 15feb2056, USD (2016-02) (XS1389124774) |
| UBS Group, 2.125% 12sep2025, GBP (10) (CH0379268722) |
| CEVA Logistics, 5.25% 1aug2025, EUR (XS1860570404) |
| UBS Group, 5.875% perp., SGD (CH0447353704) |
| Julius Baer Bank, 2.375% perp., CHF (CH0481013784) |
| Eurofima, 0% 28jul2026, EUR (204, 2191D) (XS2210044009) |
| Lindt & Spruengli, 0.01% 6oct2028, CHF (CH0564642079) |
| Nestle S.A., 0% 3dec2025, EUR (104, 1826D) (XS2263684180) |
| UBS Group, 3.091% 14may2032, USD (USH3698DDH47) |
| Nestle S.A., 0% 14jun2026, EUR (107, 1826D) (XS2350621863) |
| Glencore International AG, 0.5% 7sep2028, CHF (36) (CH1132966263) |
Bond Screener